Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 3;10(10):1203.
doi: 10.3390/antibiotics10101203.

Susceptibility of Ocular Staphylococcus aureus to Antibiotics and Multipurpose Disinfecting Solutions

Affiliations

Susceptibility of Ocular Staphylococcus aureus to Antibiotics and Multipurpose Disinfecting Solutions

Madeeha Afzal et al. Antibiotics (Basel). .

Abstract

Staphylococcus aureus is a frequent cause of ocular surface infections worldwide. Of these surface infections, those involving the cornea (microbial keratitis) are most sight-threatening. S. aureus can also cause conjunctivitis and contact lens-related non-infectious corneal infiltrative events (niCIE). The aim of this study was to determine the rates of resistance of S. aureus isolates to antibiotics and disinfecting solutions from these different ocular surface conditions. In total, 63 S. aureus strains from the USA and Australia were evaluated; 14 were from niCIE, 26 from conjunctivitis, and 23 from microbial keratitis (MK). The minimum inhibitory (MIC) and minimum bactericidal concentrations (MBC) of all the strains to ciprofloxacin, ceftazidime, oxacillin, gentamicin, vancomycin, chloramphenicol, azithromycin, and polymyxin B were determined. The MIC and MBC of the niCIE strains to contact lens multipurpose disinfectant solutions (MPDSs) was determined. All isolates were susceptible to vancomycin (100%). The susceptibility to other antibiotics decreased in the following order: gentamicin (98%), chloramphenicol (76%), oxacillin (74%), ciprofloxacin (46%), ceftazidime (11%), azithromycin (8%), and polymyxin B (8%). In total, 87% of all the isolates were multidrug resistant and 17% of the isolates from microbial keratitis were extensively drug resistant. The microbial keratitis strains from Australia were usually susceptible to ciprofloxacin (57% vs. 11%; p = 0.04) and oxacillin (93% vs. 11%; p = 0.02) compared to microbial keratitis isolates from the USA. Microbial keratitis isolates from the USA were less susceptible (55%) to chloramphenicol compared to conjunctivitis strains (95%; p = 0.01). Similarly, 75% of conjunctivitis strains from Australia were susceptible to chloramphenicol compared to 14% of microbial keratitis strains (p = 0.04). Most (93%) strains isolated from contact lens wearers were killed in 100% MPDS, except S. aureus 27. OPTI-FREE PureMoist was the most active MPDS against all strains with 35% of strains having an MIC ≤ 11.36%. There was a significant difference in susceptibility between OPTI-FREE PureMoist and Biotrue (p = 0.02). S. aureus non-infectious CIE strains were more susceptible to antibiotics than conjunctivitis strains and conjunctivitis strains were more susceptible than microbial keratitis strains. Microbial keratitis strains from Australia (isolated between 2006 and 2018) were more susceptible to antibiotics in comparison with microbial keratitis strains from the USA (isolated in 2004). Most of the strains were multidrug-resistant. There was variability in the susceptibility of contact lens isolates to MPDSs with one S. aureus strain, S. aureus 27, isolated from niCIE, in Australia in 1997 being highly resistant to all four MPDSs and three different types of antibiotics. Knowledge of the rates of resistance to antibiotics in different conditions and regions could help guide treatment of these diseases.

Keywords: MPDS susceptibility; Staphylococcus aureus; antibiotic susceptibility; conjunctivitis; corneal infiltrative events; microbial keratitis.

PubMed Disclaimer

Conflict of interest statement

All the authors declare no conflict of interest.

References

    1. Mainous A.G., 3rd, Hueston W.J., Everett C.J., Diaz V.A. Nasal carriage of Staphylococcus aureus and methicillin-resistant S. aureus in the United States, 2001–2002. Ann. Fam. Med. 2006;4:132–137. doi: 10.1370/afm.526. - DOI - PMC - PubMed
    1. Schaefer F., Bruttin O., Zografos L., Guex-Crosier Y. Bacterial keratitis: A prospective clinical and microbiological study. Br. J. Ophthalmol. 2001;85:842–847. doi: 10.1136/bjo.85.7.842. - DOI - PMC - PubMed
    1. Mah F.S., Davidson R., Holland E.J., Hovanesian J., John T., Kanellopoulos J., Shamie N., Starr C., Vroman D., Kim T., et al. Current knowledge about and recommendations for ocular methicillin-resistant Staphylococcus aureus. J. Cataract Refract. Surg. 2014;40:1894–1908. doi: 10.1016/j.jcrs.2014.09.023. - DOI - PubMed
    1. Green M., Carnt N., Apel A., Stapleton F. Queensland microbial keratitis database: 2005–2015. Br. J. Ophthalmol. 2019;103:1481–1486. doi: 10.1136/bjophthalmol-2018-312881. - DOI - PubMed
    1. Jin H., Parker W.T., Law N.W., Clarke C.L., Gisseman J.D., Pflugfelder S.C., Wang L., Al-Mohtaseb Z.N. Evolving risk factors and antibiotic sensitivity patterns for microbial keratitis at a large county hospital. Br. J. Ophthalmol. 2017;101:1483–1487. doi: 10.1136/bjophthalmol-2016-310026. - DOI - PubMed

LinkOut - more resources